|Previous Section||Index||Home Page|
|Table 3: Number of positive chlamydia screens by sex, NSCP, 2003-07|
|(1) Data are available for the period 1 April 2007 to 31 December 2007. Data as at 27 February 2008. Source: The Health Protection Agency (HPA)NCSP Core Dataset.|
|Table 4: Proportion of males and females who were screened and tested positive and the total number of positive chlamydia screens as part of the National Chlamydia Screening Programme: 2003-07|
|Proportion (percentage) positive male||Proportion (percentage) positive female||Total number positive( 1)|
|(1) Total number screened excluding screens with sex marked as unknown, unspecified, or missing. (2) Data are available for the period 1 April 2007 to 31 December 2007. Data as at 27 February 2008. Notes: 1. The data from the NCSP Core Dataset are for positive chlamydia screens made outside of GUM clinics only and include positive screens made by the Boots pathfinder project. 2. The data available from the NCSP are the number of positive screens made and not the number of patients who tested positive. 3. The data include those aged 13 to 24 only. 4. The NCSP began screening on 1 April 2003. 5. The data are specific to the financial year 1 April to March: 2003-04, 2004-05, 2005-06 and 2006-07. 6. The increase in number of positive chlamydia screens each year may also be due to an increase in screening volumes. Source: The HPANCSP Core Dataset.|
Anne Milton: To ask the Secretary of State for Health which national information resources on the subject of chlamydia were produced by (a) his Department and (b) his Departments arms length bodies in each year since 1997; what the date of publication or release was of each; what the cost to the public purse of producing these resources was in each year; and if he will make a statement. 
Dawn Primarolo: Expenditure since 1997 on sexual health campaigns is in the following table. It is not possible to separate resources on chlamydia specifically from the overall programme of work. This work includes prevention of sexually transmitted infections, HIV public education, contraception awareness and public helplines.
|(1) Provisional figure.|
Anne Milton: To ask the Secretary of State for Health (1) when the National Chlamydia Screening programme invited feedback from local and regional networks on men's perceptions and experiences of chlamydia screening, as stated in the Health Protection Agency's Men too... strategy; what feedback has been received; from which networks; for how long he plans the programme of inviting feedback to continue; and if he will make a statement; 
(2) what steps the National Chlamydia Screening programme is supporting at a local level to (a) raise men's awareness of chlamydia screening, (b) address men's concerns about the chlamydia screening process and (c) dispel misconceptions about the screening process amongst men, as described in the Health Protection Agency's Men too... strategy; 
(3) what progress the Health Protection Agency has made in reviewing existing (a) practice and (b) evidence to determine the best ways of engaging young men in chlamydia screening, as stated in the Health Protection Agency's Men too... strategy; 
(5) what progress the Health Protection Agency has made in developing (a) background information, (b) guidance and (c) a toolkit for local use, as described in the Health Protection Agency's Men too... strategy; when he plans each of these resources to become available; which parties the Health Protection Agency is consulting on developing the resources; and if he will make a statement; 
(4) which (a) individuals, (b) organisations and (c) other parties the Health Protection Agency is consulting in order to further develop the steps proposed in the Health Protection Agency's Men too... strategy; 
The National Chlamydia Screening programme (NCSP) published the Men too Strategy in November 2007 in response to the variation observed
in the proportion of men screened in the local Chlamydia Screening programmes. All chlamydia screening offices (CSOs) have been made aware of the need to address the issue of equitable access to screening.
Discussions on ways to increase uptake amongst men have been undertaken at a number of region-wide chlamydia screening co-ordinator networks. Work in relation to identifying interventions supporting male engagement and the success of each activity is underway through consultation with local Chlamydia Screening programmes. This feedback will be collated to inform a working group which has been convened to advise and steer the implementation of the Men too Strategy later in 2008.
The working group includes representatives from the Men's Health Forum; a men's health promotion specialist from a primary care trust (PCT); a sexual health network director, who commissions and facilitates sexual health service provision; the chief executive of Brook, the young persons sexual health service; and a CSO coordinator.
To date, examples of local initiatives include the Greater Manchester strategy to use sport to engage male participation in screening. In partnership with both Oldham Athletic Football Club and Oldham Rougheyeds Rugby Team, targeted sexual health education and chlamydia screening of the playing staff is being undertaken followed by a mass screening event for fans on match day. Chlamydia information and promotion of screening will be included in match day programmes for four weeks prior to the screening event.
Other relevant work includes participation in the forthcoming Men's Health Week in June 2008. This week will have a focus on the workplace and will provide an opportunity to raise awareness, address men's concerns and dispel misconceptions about the chlamydia screening process. There will also be engagement with key media organisations whose target audience is young men.
Access to screening for men is monitored quarterly by the Health Protection Agency by measuring at PCT and local programme level the proportion of screens that are taken up by men. These figures are currently fed back quarterly to the programme areas. These figures will be available on the NCSP website later this year.
Anne Milton: To ask the Secretary of State for Health what targets he expects to set for primary care trusts for chlamydia screening in 2008-09; and how much central funding was given to the NHS for chlamydia screening in each year since 1997-98. 
From 2006-07, funding to support chlamydia screening was not allocated separately to PCTs but is contained within the mainstream revenue allocations made to PCTs. The 2006-07 and 2007-08 revenue allocations to PCTs separately identified £211 million in 2006-07 and £342 million in 2007-08, around half of the £1 billion promised to support implementation of the Choosing Health White Paper. For the two years covered by this allocation, a total of £70 million was identified nationally to invest in chlamydia screening.
From 2008-09 this funding has been included in PCT baselines. It is the responsibility of PCTs to commission the health services they need to meet the health requirements of the local populations they serve.
Anne Milton: To ask the Secretary of State for Health what (a) monitoring and (b) evaluation of measures to support equitable access to chlamydia screening (i) his Department and (ii) the Health Protection Agency has undertaken in the last 12 months; and if he will make a statement. 
Dawn Primarolo: The National Chlamydia Screening Programme is undertaking research, to explore the relationship between deprivation, screening volumes and chlamydia positivity. The work will be used to develop an evaluation process that can be used to improve equitable access to the screening programme.
Anne Milton: To ask the Secretary of State for Health what proportion of screens for chlamydia undertaken in the most recent year for which figures are available were in (a) men and (b) women, broken down by chlamydia screening programme area. 
Table one shows the number of chlamydia screens among those aged 13-24 years broken down by sex and programme area for England, as part of the NCSP for the period 1 April 2006 to 31March 2007. Table two shows the proportion male and female who were screened for chlamydia by programme area, among those aged 13-24 years as part of the NCSP for the period 1 April 2006 to 31 March 2007.
|Table One: Number of screens by sex and NCSP programme area for the period 1 April 2006 to 31 March 2007|
|Programme area||Unknown/not specified||Males||Females||Total|
|(1) Cell sizes between 1 and 4 (and totals that would allow for them to be deduced) have been masked to prevent deductive disclosure in accordance with ONS guidelines.|
Data as at February 2008.
Health Protection Agency (HPA)NCSP.
|Next Section||Index||Home Page|